Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ravaud

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
British Journal of Cancer|December 17, 2003
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trialA Ravaud, N Trufflandier, J M Ferrière, et al.
Bulletin Du Cancer|November 1, 1991
[Adverse effects of interleukin 2]A Ravaud, S Negrier, F Lakdja, et al.
British Journal of Cancer|June 1, 1994
Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinomaA Ravaud, S Négrier, L Cany, et al.
British Journal of Cancer|November 1, 1992
Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trialsA Ravaud, N B Bui, J M Coindre, et al.
Cancer Treatment Reviews|June 10, 2021
Checkpoint inhibitors in metastatic papillary renal cell carcinomaM de Vries-Brilland, D F McDermott, C Suárez, et al.
Blood|July 10, 1998
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapyJ Y Blay, A Le Cesne, C Mermet, et al.
European Radiology|August 14, 2014
Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinomaF Cornelis, E Tricaud, A S Lasserre, et al.
European Radiology|February 22, 2014
Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumoursF Cornelis, E Tricaud, A S Lasserre, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Bernhard, A Ravaud, Y Grassano, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
British Journal of Cancer|December 17, 2003
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trialA Ravaud, N Trufflandier, J M Ferrière, et al.
Bulletin Du Cancer|November 1, 1991
[Adverse effects of interleukin 2]A Ravaud, S Negrier, F Lakdja, et al.
British Journal of Cancer|June 1, 1994
Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinomaA Ravaud, S Négrier, L Cany, et al.
British Journal of Cancer|November 1, 1992
Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trialsA Ravaud, N B Bui, J M Coindre, et al.
Cancer Treatment Reviews|June 10, 2021
Checkpoint inhibitors in metastatic papillary renal cell carcinomaM de Vries-Brilland, D F McDermott, C Suárez, et al.
Blood|July 10, 1998
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapyJ Y Blay, A Le Cesne, C Mermet, et al.
European Radiology|August 14, 2014
Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinomaF Cornelis, E Tricaud, A S Lasserre, et al.
European Radiology|February 22, 2014
Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumoursF Cornelis, E Tricaud, A S Lasserre, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Bernhard, A Ravaud, Y Grassano, et al.
Pageof 11